logo

Lannett Co Inc (LCI)



Trade LCI now with
  Date
  Headline
8/26/2020 4:33:23 PM Lannett Q4 Loss/share $0.25 Vs. Loss $0.20 Year Ago
8/17/2020 7:05:38 AM Lannett Enters Exclusive US Distribution Deal For Therapeutically Equivalent Generic Of Flovent Diskus Of Respirent
8/3/2020 6:54:13 AM Lannett Announces Launch Of FDA Approved Levothyroxine Tablets
7/27/2020 6:53:39 AM Lannett To Launch Levorphanol Tablets
7/23/2020 6:52:00 AM Lannett Launches Mexiletine HCl Capsules (Press Release)
7/16/2020 6:58:05 AM Lannett, Cediprof Sign Interim Supply And Distribution Deal For Cediprof's FDA Approved Levothyroxine Sodium Tablets USP
7/13/2020 6:54:03 AM Lannett To Reduce Workforce By 80 Positions; Expects Cost Savings In Excess Of $15 Mln Annually
6/11/2020 6:56:30 AM Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine
3/31/2020 6:55:24 AM Lannett Company Commences Marketing A Generic Version Of Adderall XR®
1/13/2020 6:54:12 AM Lannett Announces FDA Approval Of NDA For Branded Anesthetic Product, Cocaine Hydrochloride Nasal Solution 4%
1/6/2020 6:53:25 AM Lannett Launches Venlafaxine ER Tablets And Lidocaine Topical Solution 4%